A Phase 3, Randomized, Double-Blind, Placebo Controlled Study to Compare Efficacy and Safety of Oral Azacitidine Plus Best Supportive Care as Maintenance Therapy in Subjects with Acute Myelogenous Leukemia in Complete Remission - Regional Cancer Care Associates LLC

Clinical Trials

A Phase 3, Randomized, Double-Blind, Placebo Controlled Study to Compare Efficacy and Safety of Oral Azacitidine Plus Best Supportive Care as Maintenance Therapy in Subjects with Acute Myelogenous Leukemia in Complete Remission

Type of Cancer
Leukemia
Locations
Hackensack
Sponsor
Celgene
Protocol Number
CC-486-AML-001
Cancer Diagnosis
To Learn More Call
201-510-0910